drugset

drugset / Trial / NCT00168350

Memantine in Patients With Chronic Glaucoma

NCT00168350 ↗

Phase 3 Completed 1179 enrolled Allergan

RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized double-masked clinical trial of memantine in patients with glaucoma

Timeline

Start: 2000-03
Primary completion: 2006-09
Completion: 2006-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Memantine	Unknown	—	—

Indications